The Man Who Wrote the DSM Warned Us About Overdiagnosis — So Why Not Gender? - Allen Frances (#8)
10 April 2025
With Allen Frances
therapy-and-psychology
Allen Frances helped draft the diagnostic bible of modern psychiatry and spent decades warning that it was being misused — that ordinary suffering was being turned into disorder, and that caution should always prevail. This episode puts that principle under pressure. The conversation moves from ADHD to autism to gender dysphoria, and something unexpected happens: the man who built the case for diagnostic scepticism finds himself unwilling to apply it consistently to gender. The episode is most valuable for what that inconsistency reveals about how ideological pressures shape even the most rigorous minds.
Allen Frances occupies a peculiar position in the history of modern psychiatry. As the chair of the DSM-IV Task Force, he helped codify the diagnostic language that clinicians worldwide still use. But he is perhaps better known for what happened next: years of public warning that psychiatry had overshot, that the manual he helped create had been used to pathologise ordinary human suffering, and that pharmaceutical companies had exploited loosely drawn diagnostic thresholds to expand their markets into territory that belonged to normal life. That argument — that diagnosis should be cautious, that labels have consequences, that watchful waiting is usually the most responsible clinical position — runs through the first half of this conversation like a spine. Frances is compelling on the mechanics of overdiagnosis: how a label, once applied, tends to become permanent; how online communities form around diagnoses and entrench them as identities; how the explosion in autism rates reflects not a genuine epidemiological shift but a social and institutional response to a broadening definition. The hosts follow him willingly through this terrain, because the logic applies with obvious force to the rapid rise in adolescents presenting with gender dysphoria. Then the conversation reaches gender, and something shifts. Frances, who had advocated for removing gender identity from the DSM altogether, finds himself unwilling to extend his own analytical framework to this case. He acknowledges confusion — 'I'm confused because it's confusing,' he says — but that acknowledgement does not lead to the kind of cautious scepticism he applies elsewhere. The divergence is not hidden; the hosts press him directly, and the tension is left in the recording rather than edited out. The result is one of the more intellectually honest moments the podcast has produced. What this episode maps, without quite naming it, is the difference between a principle and its application. Frances built his reputation on one principle: that psychiatric diagnosis carries risks, that mild problems can be turned into permanent identities, and that institutional and commercial pressures distort clinical judgment. The question the episode poses is why that principle, applied so readily to ADHD and depression and autism, encounters such resistance when it arrives at gender. The answer is not found here — Frances does not fully provide it — but the shape of the resistance is visible, and that matters. The broader lesson concerns how institutions behave under ideological pressure. Diagnostic systems are not neutral scientific instruments; they are social constructs maintained by professional bodies, shaped by advocacy, and subject to the same cultural currents that move everything else. Frances understands this better than almost anyone. The episode's tension arises because a man who has spent decades pointing at that mechanism seems, in one specific domain, unable to fully see it operating. That is not a reason to dismiss him — his insights on overdiagnosis, labelling and the pharmaceutical industry remain sharp — but it is a reason to notice what ideological capture looks like even in rigorous minds.
